Fragmented Markets for Older Antibiotics in Scandinavia
Author Information
Author(s): Christine Årdal, Mohamed Gawad, Enrico Baraldi, Marianne Jahre, Charlotta Edlund
Primary Institution: Norwegian Institute of Public Health
Hypothesis
How does market fragmentation affect the availability of older antibiotics in Denmark, Norway, and Sweden?
Conclusion
Market fragmentation in Scandinavia leads to inconsistent availability of essential antibiotics, particularly for children.
Supporting Evidence
- Antibiotic resistance is a major public health threat.
- Narrow-spectrum antibiotics are effective but often not marketed in all countries.
- Market fragmentation leads to fewer available formulations for critical antibiotics.
Takeaway
Different countries in Scandinavia have trouble getting the same antibiotics for kids because they don't sell the same kinds. This makes it hard for doctors to treat children properly.
Methodology
The study examines antibiotic market fragmentation and its impact on availability in Scandinavia.
Limitations
The study does not quantify the exact impact of market fragmentation on antibiotic availability.
Participant Demographics
The study focuses on the antibiotic markets in Denmark, Norway, and Sweden.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website